Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1363 results
Anaptysbio announces issuance of US patent covering antibody humanization technology
AnaptysBio has announced today that the US Patent and Trademark Office (USPTO) has issued US Patent #8,685,897 broadly covering a novel approach to antibody humanization using somatic hypermutation.
Automation > IT & Software > News
Cancer Genetics expands BioDiscovery’s nexus copy number platform
Cancer Genetics and BioDiscovery have expanded the Nexus Copy Number Discovery platform in CGI research to uncover new biomarkers which are predictive of cancer outcomes.
Automation > IT & Software > News
Alacris to use SAP HANA platform for ModCell system
Alacris Theranostics has entered into a project with SAP to use the SAP HANA platform to enable Alacris' proprietary ModCell system.
Automation > IT & Software > News
Nuvilex retains TD2 to carryout preclinical, clinical studies for treatment of pancreatic cancer
Nuvilex (NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, has signed a Master Services Agreement with Translational Drug Development (TD2) pursuant to which TD2 will conduct preclinical and clinical studies in support of the development of Nuvilex's pancreatic cancer and other treatments utilizing Cell-in-a-Box technology.
Automation > IT & Software > News
Advaxis receives notice of allowance from USPTO for cancer immunotherapy platform technology
Advaxis has announced that the US Patent and Trademark Office (USPTO) has issued a notice of allowance for three US patent applications (12/213,696, 13/254,607, and 11/415,271) with claims of each application related to the company's proprietary cancer immunotherapy platform technology.
Automation > IT & Software > News
GSK uses Novozymes’ VELTIS half-life extension technology in its type 2 diabetes drug
Novozymes Biopharma, a subsidiary of Novozymes, has announced that its albumin-based VELTIS half-life extension technology is being used by GlaxoSmithKline (GSK) in the recently authorized Eperzan (albiglutide) for the treatment of type 2 diabetes in Europe.
Automation > IT & Software > News
Caris Life Sciences improves clinical use of tumor profiling service
Caris Life Sciences, a US-based biosciences firm focused on fulfilling the promise of personalized medicine, continues to enhance its comprehensive tumor profiling service, Caris Molecular Intelligence, now capable of providing an industry-leading 51 drug target associations, including exciting new immunologically-based drug targets.
Automation > IT & Software > News
iBio receives patent allowances for pandemic influenza therapeutics
iBio, a developer of proprietary products and product licenses, based on its proprietary iBioLaunch and iBioModulator platforms, has reported the allowance of two US patents for monoclonal antibodies targeting influenza.
Automation > IT & Software > News
Otsuka, IBM to develop transformative care coordination solution
By PBR Staff Writer
Japan-based Otsuka Pharmaceutical (Otsuka) and US-based multinational technology and consulting firm IBM are teaming up to deliver a new solution to improve care coordination in the mental health community.
Automation > IT & Software > News
NeoStem signs research collaboration agreement for treatment of skin wounds in scleroderma
By PBR Staff Writer
NeoStem has inked an agreement for a research collaboration aimed at investigating the potential of very small embryonic-like stem cells (VSELs) in treating difficult to heal wounds in an animal model of scleroderma.
Automation > IT & Software > News
Access Pharmaceuticals Cobraxane offers enhanced tumor growth inhibition in tumor models
Access Pharmaceuticals has announced that it is leveraging its proprietary CobaCyte drug delivery platform technology to create new formulations of active pharmaceutical agents.
Automation > IT & Software > News
N-of-One, BioDiscovery to offer integrated genomic analysis interpretation solutions
By PBR Staff Writer
BioDiscovery and N-of-One, a provider of molecular interpretation and therapeutic strategies for precision medicine in oncology, have entered into a partnership to jointly provide integrated genomic analysis interpretation solutions.
Automation > IT & Software > News
NanoViricides announces issuance of fundamental patents in Australia and Philippines
NanoViricides has announced today that a fundamental PCT patent application, on which the nanoviricides technology is based, has resulted in additional issued patents in Australia and the Philippines.
Automation > IT & Software > News
Nuvilex contracts with Austrianova for cGMP-compliant Cell-in-a-Box encapsulation of cells for clinical trials
Nuvilex has contracted with Austrianova Singapore, a subsidiary of SG Austria in which Nuvilex is a partial owner, to perform the cGMP (current Good Manufacturing Practices)-compliant encapsulation of live cells to be used for Nuvilex's clinical trials in patients with advanced, inoperable pancreatic cancer and associated conditions and other types of cancer.
Automation > IT & Software > News
Lonza and BioWa sign licensing agreement with arGEN-X for POTELLIGENT technology
By PBR Staff Writer
Kyowa Hakko Kirin's US subsidiary BioWa and Swiss chemicals and biotechnology firm Lonza have entered into a licensing agreement with arGEN-X BV, a Dutch clinical-stage human therapeutic antibody company.
Automation > IT & Software > News
91-105 of 1363 results